Clinical Trials Browser

Phase 2 × Canvaxin × Clear all

NCT00004104 2016-03-31

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Phase 2 Completed

Melanoma

NCT00128583 2013-12-19

Vaccine Therapy in Treating Patients With Malignant Melanoma

Phase 2 Unknown

Melanoma